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Failure of Trafficking and Antigen Presentation
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tide complexes then traffic to the cell surface and stimu-
late CD4 helper T cells to produce immunoregulatory
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gens (Moody et al., 2000; Park and Bendelac, 2000;Summary
Prigozy and Kronenberg, 1998; Schaible and Kaufmann,
2000; Stenger et al., 1997). In mycobacteria-infectedEndocytosed microbial antigens are primarily deliv-
cells, lipids and glycolipids derived from phagosome-ered to lysosomal compartments where antigen bind-
resident mycobacteria escape from phagosomes anding to MHC and CD1 molecules occurs in an acidic and
distribute to other subcompartments of the endocyticproteolytically active environment. Signal-dependent
system, including early recycling endosomes and lyso-delivery to lysosomes has been suggested for these
somes, to which CD1a and CD1b traffic for samplingantigen-presenting molecules, but molecular interac-
antigens, respectively (Beatty et al., 2000; Sugita et al.,tions with vesicular coat proteins and adaptors that
2000a). The trafficking routes for these two CD1 iso-direct their lysosomal sorting are poorly understood.
forms appear to be distinct. CD1a is localized to earlyHere CD1b but not other CD1 isoforms bound the AP-3
recycling endosomes and follows an ARF6-dependentadaptor protein complex. In AP-3-deficient cells de-
pathway (Sugita et al., 1999). In contrast, CD1b is largelyrived from patients with Hermansky-Pudlak syndrome
excluded from early recycling endosomes and localizestype 2 (HPS-2), CD1b failed to efficiently gain access
almost exclusively deep in late endosomes and lyso-to lysosomes, resulting in a profound defect in antigen
somes (Prigozy et al., 1997; Sugita et al., 1996).presentation. Since MHC class II traffics normally in
In contrast to live mycobacteria that reside in phago-AP-3-deficient cells, defects in CD1b antigen presen-
somes, dead mycobacteria as well as most extracellulartation may account for recurrent bacterial infections
microbes that are phagocytosed by antigen-presentingin HPS-2 patients.
cells (APCs) are subsequently delivered to the acidic
environment of lysosomes (Kaufmann, 1993). SamplingIntroduction
of lysosomes is crucial for effective antigen presentation
mediated by MHC class II and CD1b molecules. Both
In order to detect infection efficiently, antigen-present-
molecules are delivered efficiently to a specialized lyso-
ing molecules are elaborately directed to distinct intra-
somal compartment, called the MHC class II compart-
cellular compartments where they can intersect with ment or MIIC, where antigen loading is proposed to
and bind foreign antigens. Peptide antigens generated occur (Peters et al., 1991, 1995b; Sugita et al., 1996).
in the cytosol, such as those derived from virus-infected Specific cytoplasmic tail signals that dictate their intra-
cells, are transported through the TAP transporter into cellular trafficking have been identified for both MHC
the lumen of the endoplasmic reticulum (ER). The pep- class II and CD1b molecules. Following assembly with
tide antigens are then sampled in the ER by MHC class I the invariant chain (Ii) in the ER, MHC class II molecules
molecules that are largely retained in the ER until peptide are sorted to the MIIC by utilizing two dileucine-based
binding occurs (Heemels and Ploegh, 1995). MHC class sorting signals present within the cytoplasmic domain
I-peptide complexes then traffic to the cell surface to of Ii as well as an additional dileucine-based signal in
activate CD8 T cell responses. In contrast, microbes the MHC class II  chain (Bakke and Dobberstein, 1990;
and their products present in the extracellular space Lotteau et al., 1990). In contrast, the short cytoplasmic
are endocytosed and delivered to late endosomes and domain of CD1b contains a tyrosine-based sorting motif
lysosomes for degradation into peptides. Subsequently, (YXXZ, where Y is tyrosine, X is any amino acid, and Z
these peptides are sampled by MHC class II molecules is a bulky hydrophobic amino acid) that is crucial for its
that are targeted to these compartments by the associ- localization to the MIIC (Jackman et al., 1998). Surpris-
ated invariant chain (Cresswell, 1994). MHC class II-pep- ingly, CD1c also contains a similar tyrosine-based motif,
but its intracellular localization is less focused on lyso-
somes. In fact, CD1c molecules, while more promiscu-4 Correspondence: mbrenner@rics.bwh.harvard.edu
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ous in their endosomal distribution, are largely found in rescence microscopic analysis of HeLa cells expressing
each CD1 isoform detected noticeable differences be-early recycling endosomes, and only a small fraction of
CD1c molecules can distribute to lysosomes (Briken et tween CD1b and other CD1 molecules in their intracellu-
lar distribution (Figure 1). As we previously showed (Su-al., 2000; Schaible and Kaufmann, 2000; Sugita et al.,
2000b). This difference in localization of CD1b and CD1c, gita et al., 1999), whereas CD1a was found in a cluster
of vesicles at a juxtanuclear position that representeddespite containing similar YXXZ sorting motifs, is under-
scored by their disparate dependence on vesicular acid- early recycling endosomes (Figure 1A, green vesicles),
CD1b was prominent in more peripherally distributedification for effective antigen presentation (Briken et al.,
2000; Sugita et al., 2000a). We hypothesized that the vesicles (Figure 1D, green vesicles) as was lysosome-
associated membrane protein-1 (LAMP-1), an endoge-CD1b and CD1c cytoplasmic tail tyrosine-based sorting
motifs might mediate interactions with distinct organel- nous marker for lysosomes (Figure 1E, red vesicles).
Electronic merging of the images revealed that thelar coats involved in protein sorting. A system of adaptor
protein (AP) complexes, AP-1, AP-2, AP-3, and AP-4, has CD1b-containing vesicles and the LAMP-1-containing
vesicles were almost entirely superimposable (Figurebeen characterized which binds both transmembrane
cargo proteins via tyrosine-based motifs and a variety 1F, yellow vesicles), confirming the prominent localiza-
tion of CD1b in lysosomes. CD1c and CD1d were alsoof peripheral vesicle-associated proteins (Kirchhausen,
1999; Robinson and Bonifacino, 2001). The AP-2 com- readily detectable in intracellular vesicles (Figures 1G
and 1J, green vesicles, respectively). Unlike CD1b, how-plex has been implicated in the internalization of many
proteins from the cell surface since it recognizes a range ever, their intracellular distribution only partially over-
lapped with that of LAMP-1 (Figures 1I and 1L), indicat-of tyrosine-based sorting motifs (Honing et al., 1996;
Ohno et al., 1995). On the other hand, the concept has ing a markedly dominant lysosomal sorting for CD1b as
compared to the other CD1 isoforms that also containedemerged that marked selectivity in recognition of tyro-
sine-based motifs may occur for other adaptor protein tyrosine-based sorting motifs.
To determine directly the ability of CD1b and CD1ccomplexes, dependent upon the sequence of the space
residues (X) in the YXXZ motif as well as flanking resi- tails to mediate protein sorting to lysosomes, wild-type
CD1b and a chimeric CD1b molecule in which CD1bdues and distance of the motif from the membrane
(Ohno et al., 1998; Rohrer et al., 1996; White et al., 1998). tail was swapped with CD1c tail (CD1b:CD1c tail) were
expressed in HeLa cells by transfection, and their intra-We hypothesized that the ubiquitous AP-3 adaptor
complex might selectively mediate sorting of CD1b to cellular localization was determined by confocal micros-
copy (Figure 2). The CD1b:CD1c tail chimeric moleculeslysosomes. This cytosolic protein complex, composed
of the four subunits 3A, , 3A, and 3 (A or B), was were expressed in intracellular vesicles (Figure 2D,
green vesicles), but, unlike wild-type CD1b, which wasshown to function in protein targeting to lysosome-
related organelles, such as melanosomes and platelet prominent in LAMP-1-containing vesicles (Figure 2, top
panels), most of these vesicles lacked LAMP-1 (Figuregranules (Dell’Angelica et al., 2000; Odorizzi et al., 1998).
AP-3-deficient mice as well as Hermansky-Pudlak syn- 2F, green vesicles indicated with arrowheads). Further,
markedly more prominent surface expression was noteddrome type 2 (HPS-2) patients with mutations in the
AP-3 3A gene exhibited hypopigmentation and platelet for the CD1b:CD1c tail chimeric molecule (Figure 2D)
than for wild-type CD1b (Figure 2A). This distribution fordysfunction (Dell’Angelica et al., 1999; Feng et al., 1999;
Kantheti et al., 1998; Shotelersuk et al., 2000; Yang et the chimeric CD1b containing the CD1c tail was similar
to that observed previously for wild-type CD1c, whichal., 2000). The ability of the 3A subunit to interact spe-
cifically with tyrosine-based motifs contained within cy- exhibited a large pool of molecules in early recycling
endosomes with a small pool in lysosomes (Sugita et al.,toplasmic domains of lysosome-resident proteins, such
as CD63 and LAMP-1, has been noted, and these pro- 2000b). Indeed, most of the CD1b:CD1c tail-containing
intracellular vesicles but not wild-type CD1b-containingteins traffic aberrantly in AP-3-deficient cells (Dell’An-
gelica et al., 1999). Here, we show that CD1b but not vesicles coexpressed the transferrin receptor, a marker
for early endosomes (data not shown), suggesting thatother CD1 isoforms binds the AP-3 complex. In AP-3-
deficient cells, CD1b fails to accumulate in lysosomal CD1c tail misrouted the chimeric CD1b molecule to early
endosomes. For comparison, another chimeric CD1bantigen binding compartments and is instead mislocal-
ized to the plasma membrane and early endosomes. molecule with the CD63 tail (CD1b:CD63 tail) was ex-
pressed in HeLa cells, and its intracellular distributionThis failure in CD1b trafficking correspondingly results
in its failure to efficiently present microbial lipid antigens was determined. Similar to wild-type CD1b, the CD1b:
CD63 tail chimeric molecule was expressed in peripher-to T cells, while other CD1 isoforms function normally.
Since MHC class II functions normally in AP-3-deficient ally distributed vesicles (Figure 2G, green vesicles), and
virtually all of the vesicles coexpressed LAMP-1 (Figurecells (Caplan et al., 2000; Sevilla et al., 2001), defects in
CD1b antigen presentation may account for bacterial 2I, yellow vesicles), demonstrating that the CD1b:CD63
tail chimeric molecule was efficiently delivered to lyso-infections in HPS-2 patients.
somes. Thus, we concluded that both the CD1b and
CD63 tails but not the CD1c tail were efficient in mediat-Results
ing protein sorting to LAMP-1-positive lysosomes.
CD1b and CD63 Cytoplasmic Tails Efficiently Mediate
Lysosomal Sorting, but Not the CD1c Tail Of the Four CD1 Isoforms, Only CD1b Binds
the AP-3 Adaptor Protein ComplexAmong the four CD1 isoforms expressed in humans,
CD1b, CD1c, and CD1d contain tyrosine-based sorting We reasoned that cytosolic proteins associated with
vesicular coats might distinctly bind the CD1b cyto-motifs in their cytoplasmic domains. Yet, immunofluo-
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Figure 1. Human CD1 Isoforms Were Differentially Transported to Lysosomes
HeLa cells transfected with either CD1a ([A]–[C]), CD1b ([D]–[F]), CD1c ([G]–[I]), or CD1d ([J]–[L]) were fixed and permeabilized, and then double
labeling with antibodies to the appropriate CD1 isoforms (green) and LAMP-1 (red) was performed. The two corresponding images were then
electronically merged (CD1  LAMP-1). Scale bars, 10 m.
plasmic tail tyrosine-based sorting motif, accounting for (TfR), and LAMP-1. The growth of the transformed yeast
cells was evaluated on histidine-supplemented andits marked delivery to lysosomes. The AP-3 adaptor
protein is known to capture selected lysosome-resident histidine-deficient plates to identify specific interac-
tions between the AP-3 3A subunit and each tyrosine-integral membrane proteins via interaction between the
3A subunit of AP3 and cytoplasmic tyrosine-based based motif containing cytoplasmic tail. Yeast cells
grew well on histidine-supplemented plates (Figure 3A,sequences of the transmembrane proteins (Dell’Ange-
lica et al., 1999). Therefore, we tested the cytoplasmic left panel,  His), confirming their viability. A specific
interaction of CD63 and LAMP-1 but not TfR with the 3Adomains of the four human CD1 isoforms (CD1a, -b,
-c, -d) for their ability to bind the 3A subunit of AP-3, subunit was demonstrated on histidine-deficient plates
(Figure 3A, right panel,  His), consistent with their pre-using a yeast two-hybrid approach (Figure 3). The GAL4
transcription activation domain was fused to 3A and viously reported specificities. Importantly, among the
four CD1 isoforms tested, only CD1b but not the otherswas coexpressed in yeast cells with the GAL4 DNA bind-
ing domain fused to the cytoplasmic tyrosine-based se- showed a striking ability to bind the 3A subunit of the
AP-3 complex in this yeast two-hybrid system (Figurequences derived from CD1a, -b, -c, and -d or from con-
trol proteins including CD63, the transferrin receptor 3A, right panel,  His). These results suggested that
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Figure 2. CD63 Tail but Not CD1c Tail Was Substituted for CD1b Tail to Deliver CD1b to LAMP-1 Lysosomes
HeLa cells transfected with either wild-type CD1b (top panels), CD1b:CD1c tail (middle panels), or CD1b:CD63 tail (bottom panels) were double
labeled with antibodies to CD1b ([A], [D], and [G]; green) and LAMP-1 ([B], [E], and [H]; red) and analyzed by confocal microscopy. The two
corresponding images were then superimposed to detect any cellular compartments expressing both CD1 and LAMP-1 ([C], [F], and [I];
yellow). Scale bars, 5 m.
CD1b molecules might be selectively delivered to lyso- tyrosine-based sorting motifs and their flanking amino
acid residues are remarkably similar between CD1bsomes via specific interaction with the AP-3 complex.
The amino acid sequence of the cytoplasmic tail (Arg-Arg-Arg-Ser-Tyr-Gln-Asn-Ile-Pro) and CD1c (Lys-
Figure 3. CD1b but Not Other CD1 Isoforms
Binds the 3A Subunit of the AP-3 Complex
(A) Yeast cells were transformed with the
GAL4ad-3A construct together with either
GAL4bd-CD63, GAL4bd-TfR, GAL4bd-LAMP-1,
GAL4bd-CD1a, GAL4bd-CD1b, GAL4bd-CD1c,
or GAL4bd-CD1d and plated on minimal me-
dium plates with ( His) or without ( His)
histidine. Specific interaction was detected
based on the ability of the cotransformed
yeast cells to grow in the absence of histidine.
(B) Yeast cells were transformed with the
GAL4ad-3A construct together with GAL4bd
fused with either CD1c-based (top) or CD1b-
based (bottom) tail constructs. Their amino
acid sequences are shown in the legends,
with mutated amino acid residues underlined.
The transformed cells were inoculated in his-
tidine-deficient media, and their growth was
assessed by measuring OD600 at indicated
time points.
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Figure 4. CD1b Molecules Were Redistributed to Early Endocytic Compartments and the Plasma Membrane in AP-3-Deficient Cells
Wild-type (W1) and AP3-deficient (W2) cells were transfected with CD1b, double labeled with antibodies to CD1b ([A] and [D]; red) and to TfR
([B] and [E]; green), and analyzed by confocal microscopy. The two corresponding images were then superimposed to detect intracellular
vesicles expressing both CD1b and TfR ([C] and [F]; yellow). Scale bars, 5 m.
Lys-His-Cys-Ser-Tyr-Gln-Asp-Ile-Leu) (amino acid se- cells, we compared CD1b localization in AP-3-express-
ing (W1) and AP-3-deficient (W2) cells. W2 is a B-lym-quences of the cytoplasmic domains are shown in
parentheses with tyrosine-based motifs underlined). phoblastoid cell line derived from a patient with HPS-2
who carries a single nucleotide substitution in one alleleAmong the C-terminal six amino acid residues, only
those at the Y  2 and Y  4 positions are different of the 3A gene and a 63 bp deletion in the other allele
of the gene (Dell’Angelica et al., 1999). In these cells, allbetween the two molecules. To appreciate critical resi-
dues that might control AP-3 binding, the amino acid the AP-3 complexes containing the mutated forms of
the 3A subunit fail to assemble and are proteolyticallyresidues at these positions of the CD1c tail were mu-
tated either singly or doubly into the corresponding degraded, resulting in markedly reduced levels of func-
tional AP-3 complexes. W1 is a B-lymphoblastoid cellamino acid residues of the CD1b tail (Asp to Asn at Y 
2 and Leu to Pro at Y  4), and the ability of the mutated line derived from the father of the patient, who carries
the normal 3A gene in one allele while having the 63sequences to bind the AP3 3A subunit was compared
by measuring the growth rate of transformed yeast cells bp deletion in the other allele (Dell’Angelica et al., 1999).
Thus, W1 cells express functional AP-3 complexes and(Figure 3B, top panel). No growth was detected in His-
deficient media for yeast cells expressing the CD1c tail were suitable for comparison with the AP-3-deficient
W2 cells.with the single Asp to Asn mutation at Y  2 (filled
triangle) as well as those expressing the wild-type CD1c CD1b was expressed in these cells by transfection,
and its intracellular localization was compared. In W1tail (open square). In contrast, yeast cells harboring the
Leu to Pro mutation at Y  4, either with (filled circle) cells (Figure 4, top panels), the majority of CD1b-con-
taining vesicles (Figure 4A, red vesicles) were separateor without (filled square) mutation at Y  2, significantly
restored the ability to grow in His-deficient media, sug- from TfR-expressing vesicles (Figure 4B, green vesicles)
that belonged to the early endocytic system. Consistentgesting a potential role of the C-terminal proline in posi-
tively controlling binding to AP-3. Consistent with this, with the prominent expression of CD1b in lysosomes,
few CD1b vesicles were found superimposable withmarked reduction in growth rate was observed for yeast
cells expressing the C-terminal proline deleted CD1b TfR vesicles. In contrast, in AP-3-deficient W2 cells,
markedly increased levels of surface expression oftail (Figure 3B, bottom panel, filled square), as compared
with the wild-type CD1b tail (filled circle). These observa- CD1b were observed. The CD1b vesicles visible intra-
cellularly (Figure 4D, indicated with arrowheads) dis-tions strongly suggested that the presence or absence
of the C-terminal proline residue accounted for differen- played a vesicular distribution similar to that of the TfR
(Figure 4E, green vesicles). By electronically mergingtial binding of CD1b and CD1c to AP-3.
the images, it was apparent that the CD1b-containing
and the TfR-containing vesicles were almost entirelyCD1b Molecules Are Misrouted
in AP-3-Deficient Cells superimposable (Figure 4F, yellow vesicles). These re-
sults suggested that unlike MHC class II that trafficsTo confirm that the results from the yeast two-hybrid
system were physiologically relevant in mammalian normally in AP-3-deficient cells (Caplan et al., 2000; Se-
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Figure 5. CD1b Molecules Barely Gained Ac-
cess to Lysosomes in AP-3-Deficient Cells
Immunoelectron micrographs of thin cryo-
sections of W1 (left) and W2 (right) cells trans-
fected with CD1b are shown. In W1 cells,
CD1b molecules were prominently expressed
in multuvesicular or multilamellar lysosomes
(indicated with arrows). In contrast, CD1b
molecules are poorly expressed in these
compartments (indicated with arrows) of W2
cells while being expressed abundantly on
the plasma membrane (P). Scale bars, 50 nm.
villa et al., 2001), CD1b trafficking was selectively altered deficient Jurkat cells (J.RT3) reconstituted with TCR 
and  chains derived from two mycobacterial lipid anti-to early endosomes and to the plasma membrane in AP-3-
deficient cells. One cannot readily evaluate lysosomal gen-specific T cells. LDN5/J.RT3 was obtained by trans-
fection of J.RT3 cells with the TCR  and  chain cDNAslocalization by confocal microscopy detecting colocali-
zation with lysosomal marker proteins, such as LAMP-1, isolated from the LDN5 CD1b-restricted T cell line,
whereas CD8-1/J.RT3 was obtained by transfection within AP-3-deficient cells because the distribution of these
marker proteins is known to be partially altered as a the CD8-1 CD1c-restricted T cell line. These T cells pro-
duced interleukin-2 (IL-2) in response to specific antigenresult of AP-3 deficiency (Dell’Angelica et al., 1999).
However, since AP-3-deficient cells maintain typical only when APCs expressed a relevant CD1 isoform
(Grant et al., 1999). Despite the fact that wild-type W1/lysosome morphology, we performed immunogold-
labeled transmission electron microscopy to locate ly- CD1b cells expressed less CD1b proteins than mutant
W2/CD1b cells (Figures 6A and 6B), more efficient anti-sosomes. In W1 cells transfected with CD1b, CD1b was
prominently found in compartments with multivesicular gen presentation function was detected for W1/CD1b
than for W2/CD1b APCs (Figure 6C, left). T cell activationor multilamellar morphology, the typical appearance of
the lysosome (Figure 5, left, indicated with arrows), while by the AP-3-deficient W2/CD1b cells was observed only
in the presence of the highest antigen concentrations.few gold particles were seen on the plasma membrane
(P). In contrast, CD1b molecules were detected only The impaired antigen-presentation function was not in-
herent to AP-3-deficient cells, since W2/CD1c cells wererarely in lysosomes of the AP-3-deficient cells (Figure
5, right, indicated with arrows) while being expressed more efficient than W1/CD1c cells in presenting CD1c
antigens to T cells (Figure 6C, right panel). These resultsabundantly on the plasma membrane (P). Taken to-
gether, these results indicate that the CD1b cytoplasmic established an AP-3-dependent pathway for antigen
presentation by CD1b molecules.tail selectively binds AP-3, and the AP-3 complex plays
a dominant role in the efficient transport of CD1b mole-
cules to lysosomes. Discussion
Both MHC class II and CD1b molecules intersect lyso-CD1b-Dependent Lipid Antigen Presentation
Is Defective in AP-3-Deficient Cells somal compartments for efficient sampling of exoge-
nously derived antigens. Signal-dependent vesicularDelivery of CD1b to lysosomes is crucial for its antigen
presentation function, since antigen binding to CD1b transport to lysosomes has been suggested for these
antigen-presenting molecules, but the molecular inter-requires vesicular acidification (Ernst et al., 1998; Sugita
et al., 2000b). Thus, it seems likely that AP-3 might play actions that precisely direct them remain to be eluci-
dated. Here, we demonstrated that CD1b but not othera pivotal role in CD1b-dependent antigen presentation
in vivo. To examine this directly, antigen-presentation CD1 isoforms binds the AP-3 adaptor complex that me-
diates cargo-selective transport to lysosomes. Further,function of CD1b and CD1c was evaluated in wild-type
and AP-3-deficient cells. W1 and W2 cells that were we showed that defects in AP-3 function resulted in
impaired antigen presentation by CD1b.stably transfected with either CD1b (W1/CD1b and W2/
CD1b, respectively) or CD1c (W1/CD1c and W2/CD1c, The AP-3 complex interacts with both tyrosine-based
and dileucine-based sorting signals (Darsow et al., 1998;respectively) were utilized as APCs. For detection of
antigen presentation, we used T cell receptor (TCR)- Dell’Angelica et al., 1999; Honing et al., 1998; Rapoport
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Figure 6. Lipid Antigen Presentation by CD1b but Not by CD1c Was Impaired in AP-3-Deficient Cells
(A) W1 and W2 cells stably transfected with either CD1b (W1/CD1b and W2/CD1b, respectively) or CD1c (W1/CD1c and W2/CD1c, respectively)
were labeled with either anti-CD1b (left panels, filled), anti-CD1c (right panels, filled), or a control antibody (unfilled) and analyzed by flow
cytometry. Values of the mean fluorescence intensity (MFI) for CD1 staining are provided in each panel.
(B) An equal number (5  105 ) of W1/CD1b (lane1), W2/CD1b (lane 2), W1/CD1c (lane 3), and W2/CD1c (lane 4) cells were lysed in 0.5% Triton
X-100, and immunoprecipitation was performed with the BCD1b3.1 anti-CD1b antibody. The immunoprecipitated proteins were deglycosylated
and resolved on an SDS-PAGE followed by immunodetection of CD1b heavy chains with the R.b1 rabbit antiserum against CD1b. The band
corresponding to the CD1b heavy chain (arrow) was detected on lanes 1 and 2 but not on lanes 3 and 4.
(C) W1/CD1b (squares) and W2/CD1b (circles) were incubated overnight with indicated concentrations of purified glucose monomycolate
(GMM) and then fixed with 0.08% glutaraldehyde. The LDN5/J.RT3 cells were cultured with these fixed APCs, and IL-2 production was
measured (left panel). To detect CD1c-mediated antigen presentation, W1/CD1c (squares) and W2/CD1c (circles) were incubated overnight
with indicated concentrations of the chloroform/methanol (C/M) extract of Mycobacterium tuberculosis (strain H37Ra) and then fixed similarly.
The CD8-1/J.RT3 cells were cultured with these fixed APCs, and IL-2 production was measured (right panel).
et al., 1998; Vowels and Payne, 1998). Since MHC class brane, since recognition of this AP complex occurs for
many proteins containing tyrosine-based motifs that areII molecules are prominently expressed in lysosomes,
and dileucine-based motifs are found in the cytoplasmic internalized from the plasma membrane. For CD1b, a
multistep pathway for internalization to lysosomes maydomain of MHC class II  chains as well as the associ-
ated Ii, a role for AP-3 in MHC class II antigen presenta- first involve interactions with AP-2 at the plasma mem-
brane, followed by interactions with AP-3 in endosomestion was considered. However, recent studies in mice
and in humans demonstrated that AP-3 is not required that direct CD1b selectively to lysosomal antigen bind-
ing compartments. Most CD1c molecules are expressedfor MHC class II trafficking and peptide antigen binding
(Caplan et al., 2000; Sevilla et al., 2001). Moreover, ex- in vesicles of the early endocytic system (Briken et al.,
2000; Sugita et al., 2000b). Without such specific interac-cept for CD1b, neither the other CD1 isoforms nor MHC
class I bind AP-3. Thus, among antigen-presenting mol- tion with AP-3, CD1c molecules, like TfR, may follow an
early recycling route as a default pathway. Despite theecules, CD1b distinctly utilizes an AP-3-dependent ve-
sicular transport as shown here and also by the BIAcore fact that CD1c does not bind AP-3, a small fraction can
reach lysosomes in normal cells, and a small fractionsurface plasmon resonance spectroscopy (Briken et al.,
2002). In this respect, it is noteworthy that patients with of CD1b molecules reach lysosomes in AP-3-deficient
cells. Similarly, AP-3-deficient mice show diluted pig-HPS-2 suffer from recurrent microbial infections (Shotel-
ersuk et al., 2000), raising an interesting possibility that mentation due to impaired protein trafficking to the lyso-
some-related melanosome, but pigmentation is notdefects in CD1b function may contribute to liability to
infections. completely absent. These examples suggest that AP-3-
independent pathways for cargo-selective transport toIn contrast to the selective binding of AP-3 by CD1b,
it seems likely that other CD1 isoform tyrosine-based lysosomes must exist, and these other mechanisms may
mediate efficient transport of MHC class II-invariantmotifs may interact only with AP-2 at the plasma mem-
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tail chimeric molecule was generated by PCR using CD1b:CD1c tailchain complexes to lysosomes. In this regard, it should
in pcDNA3.1() as template DNA. Primers used were 5	-GAAACbe noted that a fraction of CD1b molecules can bind
TGTGAGAATTCTC-3	 and 5	-GGTCTAGACTACATCACCTCGTAGthe invariant chain (M.S. and M.B.B., unpublished data),
CCACTTCTGATACTCTTCATATACCATAATGCAAGGC-3	. CD1b in
and CD1d is capable of associating with the MHC class pcDNA3.1() was digested with EcoRI and XbaI, and the corre-
II/invariant chain complex (Jayawardena-Wolf et al., sponding fragment was replaced with the PCR product to generate
a plasmid encoding the CD1b:CD63 tail protein. Identity of the con-2001; Kang and Cresswell, 2002), raising an interesting
structed plasmids was confirmed by DNA sequencing.possibility that this complex might mediate an AP-3-
independent alternative pathway for some CD1 isoforms
Immunofluorescence Labeling and Confocal Microscopyto reach lysosomes.
HeLa cells were grown on glass coverslips and transfected by aIn immature dendritic cells (DCs), both MHC class II
calcium phosphate precipitation method with plasmids encodingand CD1b molecules are expressed in the MIIC to sam-
wild-type and chimeric CD1b molecules as described previously
ple endocytosed foreign antigens. Once activated by (Sugita and Brenner, 1995). Two days after transfection, the cells
various inflammatory stimuli, DCs undergo a series of were fixed with 2% formaldehyde in phosphate-buffered saline
striking changes, collectively referred to as DC matura- (PBS) for 10 min at room temperature, permeabilized with 0.2%
saponin, and then processed as previously described (Sugita et al.,tion. This involves dynamic vesicular transport and reor-
1999). Briefly, the permeabilized cells were double labeled with theganization of the lysosomal compartments that allow
BCD1b3.1 mouse monoclonal antibody against CD1b and rabbitantigen-bound class II molecules to traffic from the MIIC
polyclonal antiserum against LAMP-1, followed by incubation with
to the cell surface for T cell activation (Cella et al., 1997; FITC-conjugated donkey F(ab	)2 antibody to mouse IgG and Texas
Turley et al., 2000). In contrast, CD1b is separated from red-conjugated donkey F(ab	)2 antibody to rabbit IgG (both from
MHC class II during DC maturation, and a majority of Jackson ImmunoResearch Laboratories, Inc.) in PBS containing 5%
normal donkey serum. The labeled cells were examined using aintracellular CD1b molecules are retained in LAMP-1
Leica TCS-NT confocal laser scanning microscope fitted with kryp-lysosomal compartments (X.C. and M.B.B., unpublished
ton and argon lasers as described (Sugita et al., 1999).data). Thus, it is intriguing to hypothesize that distinct
W1 and W2 cells stably transfected with CD1b were adhered on
intracellular trafficking of MHC class II and CD1b upon glass slides by a cytospin procedure, fixed, and permeabilized as
DC maturation may be controlled by their differential described above. The permeabilized cells were labeled with the
binding affinity to AP-3. The present study provides a BCD1b antibody, followed by incubation with Texas red-conjugated
donkey F(ab	)2 antibody to mouse IgG, and then double labeled withmolecular basis for dissecting pathways for peptide and
FITC-conjugated mouse monoclonal antibody to TfR. The cells werelipid antigen presentation.
examined under confocal microscope as described above.
Experimental Procedures
Yeast Two-Hybrid Assays
Cell Lines and Antibodies The two-hybrid constructs GAL4ad-3A, GAL4bd-TfR, GAL4bd-
The J.RT3 cells reconstituted with the mycobacterial lipid antigen- CD63, and GAL4bd-LAMP-1 have been described previously
specific, CD1-restricted TCRs (LDN5/J.RT3 and CD8-1/J.RT3) have (Dell’Angelica et al., 1999). The constructs for GAL4bd fused to
been described (Grant et al., 1999). These TCR-reconstituted cells either CD1a, CD1b, CD1c, or CD1d were generated by ligation of
were cultured in RPMI 1640 (GIBCO–BRL, Gaithersburg, MD) com- the GAL4bd construct with synthetic double-strand DNAs encoding
plete medium (10% heat-inactivated fetal calf serum, 20 mM HEPES, the whole cytoplasmic domain of each of the CD1 isoforms. Their
2 mM L-glutamine, 1 mM sodium pyruvate, 55 M 2-mercaptoetha- identity was confirmed by DNA sequencing. Transformation of Sac-
nol [all from GIBCO–BRL]), containing G418 (GIBCO–BRL) (1 mg/ charomyces cerevisiae strain HF7c with the above constructs and
ml) and hygromycin B (GIBCO–BRL) (500 g/ml). The wild-type (W1) subsequent growth assays on histidine-supplemented and histi-
and the AP-3-deficient (W2) human B-lymphoblastoid cell lines have dine-deficient agar plates or in histidine-deficient liquid media were
been described (Dell’Angelica et al., 1999). These cells were trans- performed as described previously (Dell’Angelica et al., 1999).
fected by electroporation with either CD1b in pCEP4 or CD1c in
pCEP4 and cultured in RPMI 1640 complete medium containing
Immunogold-Labeled Electron Microscopyhygromycin B (10 g/ml). The high-expressing cells were collected
W1 and W2 cells transfected with CD1b were fixed with 2% para-by fluorescence-activated cell sorting and used for analysis. IL-
formaldehyde and 0.2% glutaraldehyde (both from Polysciences,2-dependent HT-2 cells were cultured in RPMI complete medium
Inc., Warrington PA) and processed for ultrathin cryosectioning assupplemented with 1 nM recombinant human IL-2 (Ajinomoto Co.,
described (Peters et al., 1995a). Cryosections were incubated withKawasaki, Japan). HeLa cells were grown in Dulbecco’s modified
the BCD1b3.1 anti-CD1b antibody for 45 min, washed, and thenessential medium supplemented with 10% fetal calf serum and 2
incubated with protein-A gold (EM Laboratory, Utrecht University)mM L-glutamine. The mouse monoclonal antibodies 10H3 (anti-
for 30 min. Labeled sections were viewed with a JEOL 1010 electronCD1a) (Olive et al., 1984), BCD1b3.1 (anti-CD1b) (Behar et al., 1995),
microscope.F10/21A3.1 (anti-CD1c) (Beckman et al., 1996), CD1d51 (anti-CD1d)
(Exley et al., 1997; Spada et al., 1998), and P3 (negative control)
(Sugita and Brenner, 1994), as well as rabbit polyclonal antisera Flow Cytometry and Immunoblotting
Flow cytometric analysis of W1 and W2 transfected with either CD1bagainst LAMP-1 (Carlsson et al., 1988) and CD1b (Sugita et al., 1997)
have been described. FITC-conjugated mouse monoclonal antibody or CD1c was performed as described (Pena-Cruz et al., 2001). To
detect total cellular expression of CD1b, the cells were lysed inagainst TfR was purchased from BD Bioscience Pharmingen (San
Diego, CA). 0.5% Triton X-100 in lysis buffer (150 mM NaCl, 10 mM Tris [pH
7.5], 7.5 mM iodoacetamide, and 1 mM PMSF). Immunoprecipitation
was conducted with the BCD1b3.1 anti-CD1b antibody and proteinConstruction of Plasmids Encoding Chimeric CD1b Molecules
A cDNA encoding the CD1b:CD1c tail chimeric molecule was gener- G-Sepharose (Pharmacia, Piscataway, NJ). The immunoprecipitated
proteins were deglycosylated by digestion with PNGase F (Newated by PCR using CD1b in pSR-neo as template DNA. Primers
used were 5	-GAAACTGTGAGAATTCTC-3	 and 5	-GGTCTAGAG England Biolabs, Beverly, MA) according to the manufacturer’s in-
structions. The proteins were then resolved on an SDS-PAGE gelGATGTCCTGATATGAGCAGTGCTTCTTCATATACCATAATGCAAG
GCATAG-3	. CD1b in pcDNA3.1() was digested with EcoRI and and transferred to a polyvinylidene difluoride membrane (Millipore,
Bedford, MA). The membrane was incubated with the R.b1 rabbitXbaI, and the corresponding fragment was replaced with the PCR
product to generate a plasmid encoding the CD1b:CD1c tail protein antiserum against CD1b and immunoblotting was performed using
horseradish peroxidase-conjugated protein A (Zymed, South San[CD1b:CD1c tail in pcDNA3.1()]. A cDNA encoding the CD1b:CD63
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Francisco, CA) and enhanced chemiluminescence (reagents from (1997). Inflammatory stimuli induce accumulation of MHC class II
complexes on dendritic cells. Nature 388, 782–787.DuPont NEN, Boston, MA).
Cresswell, P. (1994). Assembly, transport, and function of MHC class
T Cell Transfectants Stimulation Assay II molecules. Annu. Rev. Immunol. 12, 259–293.
W1 and W2 cells transfected with either CD1b or CD1c were incu- Darsow, T., Burd, C.G., and Emr, S.D. (1998). Acidic di-leucine motif
bated overnight with indicated concentrations of either purified glu- essential for AP-3-dependent sorting and restriction of the func-
cose monomycolate (GMM) (for LDN5/J.RT3) (gift of Dr. D.B. Moody, tional specificity of the Vam3p vacuolar t-SNARE. J. Cell Biol. 142,
Brigham and Women’s Hospital, Boston, MA) or the chloroform/ 913–922.
methanol (C/M) extract of Mycobacterium tuberculosis (strain
Dell’Angelica, E.C., Shotelersuk, V., Aguilar, R.C., Gahl, W.A., and
H37Ra) (for CD8-1/J.RT3) and washed and fixed with 0.08% glutaral-
Bonifacino, J.S. (1999). Altered trafficking of lysosomal proteins in
dehyde as described (Sugita et al., 2000b). The TCR transfectant
Hermansky-Pudlak syndrome due to mutations in the beta 3A sub-
cells (5  104 /well) were cultured with these fixed APCs in the
unit of the AP-3 adaptor. Mol. Cell 3, 11–21.
presence of 10 ng/ml phorbol myristate acetate using 96-well, flat-
Dell’Angelica, E.C., Mullins, C., Caplan, S., and Bonifacino, J.S.bottomed microtiter plates (200 l media/well). Aliquots of the cul-
(2000). Lysosome-related organelles. FASEB J. 14, 1265–1278.ture supernatants were collected after 24 hr, and the amount of IL-2
released into the supernatants was measured as described (Grant Ernst, W.A., Maher, J., Cho, S., Niazi, K.R., Chatterjee, D., Moody,
D.B., Besra, G.S., Watanabe, Y., Jensen, P.E., Porcelli, S.A., et al.et al., 1999) using the HT-2 indicator cells, whose proliferation is
dependent on IL-2. (1998). Molecular interaction of CD1b with lipoglycan antigens. Im-
munity 8, 331–340.
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